ArticleVaccines2022

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.

Nicole Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.